Opaleye Management Inc. Kezar Life Sciences, Inc. Transaction History

Opaleye Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.08 - $2.54 $352,300 - $828,558	326,204 Added 330.18%	425,000 $505,000
Q2 2023 Aug 14, 2023	SELL	$2.31 - $3.06 $1.22 Million - $1.61 Million	-526,204 Reduced 84.19%	98,796 $242,000
Q1 2023 May 12, 2023	BUY	$3.13 - $7.31 $1.96 Million - $4.57 Million	625,000 New	625,000 $1.96 Million
Q3 2021 Nov 16, 2021	SELL	$4.85 - $9.73 $3.38 Million - $6.79 Million	-697,800 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$4.93 - $6.46 $66,062 - $86,564	-13,400 Reduced 1.88%	697,800 $3.79 Million
Q1 2021 May 18, 2021	BUY	$5.24 - $6.99 $16,768 - $22,368	3,200 Added 0.45%	711,200 $4.24 Million
Q4 2020 Feb 12, 2021	BUY	$4.77 - $6.58 $143,100 - $197,400	30,000 Added 4.42%	708,000 $3.7 Million
Q3 2020 Nov 16, 2020	BUY	$4.36 - $5.5 $2.96 Million - $3.73 Million	678,000 New	678,000 $3.28 Million

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $430M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.